#intrahepaticcholangiocarcinoma search results
#AudioVisualAbstract : Adjuvant #CytotoxicChemotherapy may not be Associated with a Survival Advantage for Resected #IntrahepaticCholangiocarcinoma @michael_lidsky rdcu.be/eL9HV @rajarnarayan @SyedAAhmad5
AUGUST ISSUE: The Impact of Preoperative CA19-9 and CEA on Outcomes of Patients with #IntrahepaticCholangiocarcinoma. #hepatobiliarytumors ow.ly/IUMi50AX1PL @McMastersKelly @SocSurgOnc
SEPTEMBER ISSUE: Therapeutic Index Associated with #Lymphadenectomy Among Patients with #IntrahepaticCholangiocarcinoma: Which Patients Benefit the Most from Nodal Evaluation? ow.ly/umyb50w1HmH @McMastersKelly @SocSurgOnc
Interactive #Tumorboard #MDT discussion on #intrahepaticcholangiocarcinoma #iCCA at #ILC2022 chaired by @DrAngelaLamarca with @Alexfornergon #JulienEdeline #MariaHawkins @EASLnews @EASLedu
Spatial immunophenotypes predict clinical outcome in #intrahepaticcholangiocarcinoma 🔓#OpenAccess at👉bit.ly/44NA1RL #LiverTwitter
DECEMBER ISSUE: A Novel Classification of #IntrahepaticCholangiocarcinoma Phenotypes Using Machine Learning Techniques: An International Multi-Institutional Analysis. rdcu.be/cbyex @McMastersKelly @SocSurgOnc
JULY ISSUE: #TumorNecrosis Impacts Prognosis of Patients Undergoing Resection for T1 #IntrahepaticCholangiocarcinoma. rdcu.be/cR41U @McMastersKelly @SocSurgOnc
🆕#CPG in press❕ EASL-ILCA Clinical Practice Guidelines on the management of #IntrahepaticCholangiocarcinoma 🆓Find it here👉bit.ly/40p8suI @EASLedu @EASLnews #iCCA #LiverTwitter
FREELY AVAILABLE: The Landmark Series: #IntrahepaticCholangiocarcinoma ow.ly/CGjx50AGN0k: @McMastersKelly @SocSurgOnc
🆕Hepatology Snapshot❕ Surgical treatment of #IntrahepaticCholangiocarcinoma By @sapisochin & colleagues 🆓at👉bit.ly/3xoAjA7 #iCCA #LiverTransplantation #LiverTwitter
Circular RNA (circACTN4) could be a prognostic biomarker & therapeutic target for #ICC ➡️circACTN4 ✅highly expressed in #intrahepaticcholangiocarcinoma ✅positively associated with #tumorgrowth & #metastasis 🔓#OpenAcces at👉bit.ly/3hk8l07 #LiverTwitter
From @AnnSurgOncol: This review presents the current evidence and future perspectives on the use of circulating tumor DNA in the diagnosis, management and understanding of the prognosis of patients with #IntrahepaticCholangiocarcinoma undergoing surgery. ow.ly/g5wR50OxF7T
SEPTEMBER ISSUE: #HepaticArterialInfusionPump Chemotherapy for Unresectable #IntrahepaticCholangiocarcinoma: A Systematic Review and Meta-Analysis.rdcu.be/cWjBH @McMastersKelly @SocSurgOnc
JUNE ISSUE: Laparoscopic Approach to #IntrahepaticCholangiocarcinoma is Associated with an Exacerbation of Inadequate Nodal Staging. ow.ly/3Tel50uuwv6 @McMastersKelly @SocSurgOnc
What is the role of lymphadenectomy in #intrahepaticcholangiocarcinoma?Our @OhioStateSurg team led by @timpawlik attempts to answer in @AnnSurgOncol! link.springer.com/article/10.124…
#Livertransplantation for #intrahepaticcholangiocarcinoma is not a well known and often times overlooked option! Raising awareness about this possibility is crucial and I want to thank the #cholangiocarcinomafoundation for giving me the opportunity to speak about it!
May Issue: Benchmarks in #LiverResection for #IntrahepaticCholangiocarcinoma @timpawlik @OhioStateSurg @ARuzzenente @skmaithel @EmorySurgery @ChamoGui @uOttawaMed @BasGrootKoerkamp @ItaruEndo rdcu.be/dG5Bu @HalletJulie
#TumorBurden Dictates Prognosis Among Patients Undergoing Resection of #IntrahepaticCholangiocarcinoma : A Tool to Guide Post-Resection #AdjuvantChemotherapy? rdcu.be/cpctK @DTsilimigras @timpawlik #VisualAbstract @McMastersKelly
🧠💥 Important read for #IntrahepaticCholangiocarcinoma 💊 Adjuvant cytotoxic chemotherapy after resection → 📉 Worse RFS (p = 0.04) ⚖️ No OS benefit (42 vs 49 mo; p = 0.13) Raises key questions on who, if anyone, benefits from adjuvant therapy. #SurgOnc #LiverCancer
#AudioVisualAbstract : Adjuvant #CytotoxicChemotherapy may not be Associated with a Survival Advantage for Resected #IntrahepaticCholangiocarcinoma @michael_lidsky rdcu.be/eL9HV @rajarnarayan @SyedAAhmad5
#AudioVisualAbstract : Adjuvant #CytotoxicChemotherapy may not be Associated with a Survival Advantage for Resected #IntrahepaticCholangiocarcinoma @michael_lidsky rdcu.be/eL9HV @rajarnarayan @SyedAAhmad5
October Issue: Oncological Resectability Criteria for #IntrahepaticCholangiocarcinoma : A Preoperative Framework for Multidisciplinary Management @Jun_Kawashima_x @timpawlik @DTsilimigras @YutakaEndoSurg @GAIA2014 rdcu.be/eJmsW @vitor__moutinho @SyedAAhmad5
From the October Issue of @AnnSurgOncol: Preoperative Systemic Immune-Inflammatory Index Predicts Occult #NodalDisease in Clinically Node-Negative #IntrahepaticCholangiocarcinoma @Jun_Kawashima_x @timpawlik @Mujtabakhalil @odysseaspchatz @_BrainyMD_ @SyedAAhmad5
October Issue: Preoperative Systemic Immune-Inflammatory Index Predicts Occult #NodalDisease in Clinically Node-Negative #IntrahepaticCholangiocarcinoma @Jun_Kawashima_x @timpawlik @Mujtabakhalil @odysseaspchatz rdcu.be/eISXQ @_BrainyMD_ @SyedAAhmad5
October Issue: Preoperative Systemic Immune-Inflammatory Index Predicts Occult #NodalDisease in Clinically Node-Negative #IntrahepaticCholangiocarcinoma @Jun_Kawashima_x @timpawlik @Mujtabakhalil @odysseaspchatz rdcu.be/eISXQ @_BrainyMD_ @SyedAAhmad5
During the treatment of intrahepatic cholangiocarcinoma, maintaining a positive attitude is very important. You can communicate more with fellow patients, share experiences and feelings, and also develop some hobbie #IntrahepaticCholangiocarcinoma #MentalHealth #CancerTreatment
Understanding knowledge about intrahepatic cholangiocarcinoma can help patients and their families better cope. This cancer originates from intrahepatic bile duct cells, and its occurrence may be related to factors such as chro #IntrahepaticCholangiocarcinoma #CancerKnowledge
After intrahepatic cholangiocarcinoma treatment, reexamination during the recovery period is essential. Follow the doctor's advice, undergo imaging and other examinations on time, and closely #IntrahepaticCholangiocarcinoma #PostoperativeRehabilitation #CancerReexamination
Featured: Impact of Tumor Size on the Survival Benefit of Anatomic Versus Non-Anatomic Resection for #IntrahepaticCholangiocarcinoma . @Jun_Kawashima_x @Mujtabakhalil @timpawlik ow.ly/Uqm550Wq9rA @vitor__moutinho @SyedAAhmad5
#AudioVisualAbstract : Improving Recurrence Prediction in #IntrahepaticCholangiocarcinoma : The Synergistic Impact of the FIB-4 Index and Tumor Burden Score on Post- #Hepatectomy Outcomes @Jun_Kawashima_x @timpawlik rdcu.be/ewdyl @NabeelZafarMD @SyedAAhmad5
Honored to Contribute to the Comprehensive Review on Intrahepatic Cholangiocarcinoma - @supriyadocc @AnjanaPillaiMD | @rachnatshroff oncodaily.com/blog/intrahepa… #Cancer #IntrahepaticCholangiocarcinoma #OncoDaily #Oncology #Medicine #Health #MedEd #MedX
#AudioVisualAbstract : Anatomic Versus Non-anatomic #LiverResection for #IntrahepaticCholangiocarcinoma : A Systematic Review and Patient-Level Meta-Analysis @Giammatwit rdcu.be/emRmg @jhatjhmi1 @SyedAAhmad5
Tumor burden score and lymph node status may predict survival and the response to adjuvant chemotherapy in surgical patients with #intrahepaticCholangiocarcinoma, a form of cholangiocarcinoma. Published in @AnnSurgOncol. bit.ly/3Fjdapn #iCCA
HUTCHMED Completes Patient Recruitment in P-II Trial of Fanregratinib for Intrahepatic Cholangiocarcinoma in China pharmashots.com/21301/hutchmed… #hutchmed #fanregratinib #intrahepaticcholangiocarcinoma #nmpa #nda #fibroblastgrowthfactorreceptor #prevention #clinicaltrial #pharmashots
From the February Issue: Improving Recurrence Prediction in #IntrahepaticCholangiocarcinoma : The Synergistic Impact of the FIB-4 Index and Tumor Burden Score on Post-hepatectomy Outcomes @skmaithel @ChamoGui @ItaruEndo @timpawlik rdcu.be/ebexk @BotelhoDra @SyedAAhmad5
February Issue: Improving Recurrence Prediction in #IntrahepaticCholangiocarcinoma : The Synergistic Impact of the FIB-4 Index and Tumor Burden Score on Post-hepatectomy Outcomes @skmaithel @ChamoGui @ItaruEndo @timpawlik rdcu.be/ebexk @BotelhoDra @SyedAAhmad5
February Issue: Improving Recurrence Prediction in #IntrahepaticCholangiocarcinoma : The Synergistic Impact of the FIB-4 Index and Tumor Burden Score on Post-hepatectomy Outcomes @skmaithel @ChamoGui @ItaruEndo @timpawlik rdcu.be/ebexk @BotelhoDra @SyedAAhmad5
5/6 📌 Conclusion: RFA shows promise for iCCA, especially for tumors ≤3cm, offering survival benefits akin to resection. Crucial insights on candidate selection for optimizing treatment outcomes. 🔗 Full study: doi.org/doi:10.1016/j.… #IntrahepaticCholangiocarcinoma
#AudioVisualAbstract : Minimally Invasive Approach Provides #OncologicalBenefit in Patients with High Risk of Very Early Recurrence (VER) After Surgery for #IntrahepaticCholangiocarcinoma (iCCA) rdcu.be/d0RBZ @rajarnarayan @SyedAAhmad5
AUGUST ISSUE: The Impact of Preoperative CA19-9 and CEA on Outcomes of Patients with #IntrahepaticCholangiocarcinoma. #hepatobiliarytumors ow.ly/IUMi50AX1PL @McMastersKelly @SocSurgOnc
SEPTEMBER ISSUE: Therapeutic Index Associated with #Lymphadenectomy Among Patients with #IntrahepaticCholangiocarcinoma: Which Patients Benefit the Most from Nodal Evaluation? ow.ly/umyb50w1HmH @McMastersKelly @SocSurgOnc
🆕#CPG in press❕ EASL-ILCA Clinical Practice Guidelines on the management of #IntrahepaticCholangiocarcinoma 🆓Find it here👉bit.ly/40p8suI @EASLedu @EASLnews #iCCA #LiverTwitter
🆕Hepatology Snapshot❕ Surgical treatment of #IntrahepaticCholangiocarcinoma By @sapisochin & colleagues 🆓at👉bit.ly/3xoAjA7 #iCCA #LiverTransplantation #LiverTwitter
FREELY AVAILABLE: The Landmark Series: #IntrahepaticCholangiocarcinoma ow.ly/CGjx50AGN0k: @McMastersKelly @SocSurgOnc
May Issue: Benchmarks in #LiverResection for #IntrahepaticCholangiocarcinoma @timpawlik @OhioStateSurg @ARuzzenente @skmaithel @EmorySurgery @ChamoGui @uOttawaMed @BasGrootKoerkamp @ItaruEndo rdcu.be/dG5Bu @HalletJulie
Spatial immunophenotypes predict clinical outcome in #intrahepaticcholangiocarcinoma 🔓#OpenAccess at👉bit.ly/44NA1RL #LiverTwitter
#TumorBurden Dictates Prognosis Among Patients Undergoing Resection of #IntrahepaticCholangiocarcinoma : A Tool to Guide Post-Resection #AdjuvantChemotherapy? rdcu.be/cpctK @DTsilimigras @timpawlik #VisualAbstract @McMastersKelly
Circular RNA (circACTN4) could be a prognostic biomarker & therapeutic target for #ICC ➡️circACTN4 ✅highly expressed in #intrahepaticcholangiocarcinoma ✅positively associated with #tumorgrowth & #metastasis 🔓#OpenAcces at👉bit.ly/3hk8l07 #LiverTwitter
SEPTEMBER ISSUE: #HepaticArterialInfusionPump Chemotherapy for Unresectable #IntrahepaticCholangiocarcinoma: A Systematic Review and Meta-Analysis.rdcu.be/cWjBH @McMastersKelly @SocSurgOnc
Interactive #Tumorboard #MDT discussion on #intrahepaticcholangiocarcinoma #iCCA at #ILC2022 chaired by @DrAngelaLamarca with @Alexfornergon #JulienEdeline #MariaHawkins @EASLnews @EASLedu
JULY ISSUE: #TumorNecrosis Impacts Prognosis of Patients Undergoing Resection for T1 #IntrahepaticCholangiocarcinoma. rdcu.be/cR41U @McMastersKelly @SocSurgOnc
APRIL ISSUE: Predictors, Patterns, and Impact of Adequate #Lymphadenectomy in #IntrahepaticCholangiocarcinoma. rdcu.be/c8HH5 @McMastersKelly @SocSurgOnc
#GUTImage from the paper by Liu et al on "Targeting tumour-intrinsic N7-methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy" via bit.ly/3NRYIoS #IntrahepaticCholangiocarcinoma #PD1
SEPTEMBER ISSUE: Development and Validation of a #MachineLearningModel to Predict Early Recurrence of #IntrahepaticCholangiocarcinoma. rdcu.be/dlT9h @SocSurgOnc
JUNE ISSUE: Laparoscopic Approach to #IntrahepaticCholangiocarcinoma is Associated with an Exacerbation of Inadequate Nodal Staging. ow.ly/3Tel50uuwv6 @McMastersKelly @SocSurgOnc
DECEMBER ISSUE: A Novel Classification of #IntrahepaticCholangiocarcinoma Phenotypes Using Machine Learning Techniques: An International Multi-Institutional Analysis. rdcu.be/cbyex @McMastersKelly @SocSurgOnc
APRIL ISSUE: Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent #IntrahepaticCholangiocarcinoma. ow.ly/qBLo50yZaHF @McMastersKelly @SocSurgOnc
APRIL ISSUE: Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of #IntrahepaticCholangiocarcinoma: A Tool to Guide Post-Resection #AdjuvantChemotherapy. rdcu.be/ci8gj @McMastersKelly @SocSurgOnc
APRIL ISSUE: #NeoadjuvantChemotherapy for #IntrahepaticCholangiocarcinoma: A Propensity Score Survival Analysis Supporting Use in Patients with High-Risk Disease. rdcu.be/ciPMW @McMastersKelly @SocSurgOnc
Something went wrong.
Something went wrong.
United States Trends
- 1. #Worlds2025 30.4K posts
- 2. #TalusLabs N/A
- 3. Raindotgg 1,713 posts
- 4. Sam Houston 1,472 posts
- 5. #T1WIN 24K posts
- 6. Oregon State 4,850 posts
- 7. Boots 29.4K posts
- 8. Boots 29.4K posts
- 9. Louisville 14.5K posts
- 10. #GoAvsGo 1,535 posts
- 11. Batum N/A
- 12. UCLA 7,854 posts
- 13. Oilers 5,069 posts
- 14. #FlyTogether 2,041 posts
- 15. Miller Moss 1,221 posts
- 16. Nuss 5,839 posts
- 17. Emmett Johnson 2,483 posts
- 18. T1 FIGHTING 3,488 posts
- 19. Faker 29K posts
- 20. Hyan 1,301 posts